Cyclooxygenase Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 1706 | Acetaminophen |
| Cyclooxygenase inhibitor; may be selective for COX-3 | |
| 4092 | Aspirin |
| Cyclooxygenase inhibitor; NSAID | |
| 3786 | Celecoxib |
| Selective cyclooxygenase-2 (COX-2) inhibitor | |
| 4454 | Diclofenac sodium salt |
| Cyclooxygenase inhibitor; NSAID | |
| 1430 | DuP 697 |
| Cyclooxygenase-2 (COX-2) inhibitor | |
| 4522 | Flufenamic acid |
| Cyclooxygenase inhibitor; NSAID. Also activates TRPC6 | |
| 1507 | FR 122047 hydrochloride |
| Cyclooxygenase (COX-1) inhibitor | |
| 1708 | Indomethacin |
| Cyclooxygenase inhibitor (COX-1 > COX-2) | |
| 0942 | NS 398 |
| Cyclooxygenase-2 (COX-2) inhibitor | |
| 1418 | Resveratrol |
| Cyclooxygenase inhibitor | |
| 1550 | SC 560 |
| Cyclooxygenase-1 (COX-1) inhibitor | |
| 3919 | SC 236 |
| Selective cyclooxygenase-2 (COX-2) inhibitor | |
| 2580 | Tenidap |
| NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3 | |
| 4206 | Valdecoxib |
| Selective and potent COX-2 inhibitor |
Alzheimer's Life Science Poster
Written by Dimitra Sokolova and Soyon Hong
Our Alzheimer's disease poster summarizes the genetic, molecular and cellular changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF